PEG conjugates of potent α4 integrin inhibitors, maintaining sustained levels and bioactivity in vivo, following subcutaneous administration. (Q50930443)
Jump to navigation
Jump to search
scientific article published on 24 May 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | PEG conjugates of potent α4 integrin inhibitors, maintaining sustained levels and bioactivity in vivo, following subcutaneous administration. |
scientific article published on 24 May 2013 |
Statements
1 reference
PEG conjugates of potent α4 integrin inhibitors, maintaining sustained levels and bioactivity in vivo, following subcutaneous administration. (English)
1 reference
Jenifer L Smith
1 reference
Kassandra I Rossiter
1 reference
Christopher M Semko
1 reference
Ying-Zi Xu
1 reference
David A Quincy
1 reference
Jacek Jagodzinski
1 reference
Michael S Dappen
1 reference
Andrei W Konradi
1 reference
Christopher Vandevert
1 reference
Caroline Garrido
1 reference
Wenxian Mao
1 reference
F Bong San Pablo
1 reference
Brian Wipke
1 reference
Lilibeth Dofiles
1 reference
Angie Wadsworth
1 reference
Eric Peterson
1 reference
Carlos Lorenzana
1 reference
Stellanie Simmonds
1 reference
Elizabeth K Messersmith
1 reference
Frederique Bard
1 reference
Michael A Pleiss
1 reference
Ted A Yednock
1 reference
24 May 2013
1 reference
23
1 reference
14
1 reference
4117-4119
1 reference
Identifiers
1 reference